1. A polymorphism in the promoter is associated with EZH2 expression but not with outcome in advanced pancreatic cancer patients. (April 2014) Authors: Maftouh, Mina; Avan, Amir; Funel, Niccola; Paolicchi, Elisa; Vasile, Enrico; Pacetti, Paola; Vaccaro, Vanja; Faviana, Pinuccia; Campani, Daniela; Caponi, Sara; Mambrini, Andrea; Boggi, Ugo; Cantore, Maurizio; Milella, Michele; Peters, Godefridus J; Reni, Michele; Giovannetti, Elisa Journal: Pharmacogenomics Issue: Volume 15:Number 5(2014) Page Start: 609 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Adjuvant Chemoradiotherapy (Gemcitabine-based) in Pancreatic Adenocarcinoma: The Pisa University Experience. Issue 6 (November 2017) Authors: Sainato, Aldo; Montrone, Sabrina; Pasqualetti, Francesco; Coppola, Marianna; Cernusco, Nunzia L.V.; Panichi, Marco; Gonnelli, Alessandra; Vasile, Enrico; Morganti, Riccardo; Falcone, Alfredo; Boggi, Ugo; Paiar, Fabiola Journal: Tumori Issue: Volume 103:Issue 6(2017) Page Start: 577 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Association between DNA-repair polymorphisms and survival in pancreatic cancer patients treated with combination chemotherapy. (December 2011) Authors: Giovannetti, Elisa; Pacetti, Paola; Reni, Michele; Leon, Leticia G; Mambrini, Andrea; Vasile, Enrico; Ghidini, Michele; Funel, Niccola; Lucchesi, Matteo; Cereda, Stefano; Peters, Godefridus J; Cantore, Maurizio Journal: Pharmacogenomics Issue: Volume 12:Number 12(2012) Page Start: 1641 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Cholangiocarcinoma: Current opinion on clinical practice diagnostic and therapeutic algorithms: A review of the literature and a long-standing experience of a referral center. Issue 3 (March 2016) Authors: Brandi, Giovanni; Venturi, Michela; Pantaleo, Maria Abbondanza; Ercolani, Giorgio; Fornaro, Lorenzo; Silvestris, Nicola; Leone, Francesco; Vasile, Enrico; Lonardi, Sara; Cereda, Stefano; Santini, Daniele; Aprile, Giuseppe Journal: Digestive and liver disease Issue: Volume 48:Issue 3(2016) Page Start: 231 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Circulating microRNAs as dynamic biomarkers of response to treatment with FOLFIRINOX combination therapy in advanced pancreatic ductal adenocarcinoma. (23rd February 2017) Authors: Meijer, Laura L; Frampton, Adam E; Garajová, Ingrid; Caparello, Chiara; Le Large, Tessa Y S; Funel, Niccola; Vasile, Enrico; Stebbing, Justin; Krell, Jonathan; Kazemier, Geert; Giovannetti, Elisa Journal: Lancet Issue: Volume 389(2017)Supplement 1 Page Start: S68 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. EGF-receptor targeting with monoclonal antibodies in colorectal carcinomas: rationale for a pharmacogenomic approach. (January 2008) Authors: Loupakis, Fotios; Vasile, Enrico; Santini, Daniele; Masi, Gianluca; Falcone, Alfredo; Graziano, Francesco Journal: Pharmacogenomics Issue: Volume 9:Number 1(2008) Page Start: 55 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Evolving pancreatic cancer treatment: From diagnosis to healthcare management. (January 2022) Authors: Milella, Michele; Bassi, Claudio; Boggi, Ugo; Brunetti, Oronzo; Cavaliere, Alessandro; Crippa, Stefano; De Vita, Ferdinando; Falconi, Massimo; Frassineti, Giovanni Luca; Giommoni, Elisa; Macchini, Marina; Malleo, Giuseppe; Silvestris, Nicola; Tudisco, Antonella; Vasile, Enrico; Reni, Michele Journal: Critical reviews in oncology/hematology Issue: Volume 169(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. First-line gemcitabine plus nab-paclitaxel for elderly patients with metastatic pancreatic cancer: Crossing the frontier of age?. (September 2020) Authors: Vivaldi, Caterina; Salani, Francesca; Rovesti, Giulia; Pecora, Irene; Catanese, Silvia; Casadei-Gardini, Andrea; Massa, Valentina; Bernardini, Laura; Riggi, Laura; Andrikou, Kalliopi; Rapposelli, Giovanni I.; Formica, Vincenzo; Lencioni, Monica; Falcone, Alfredo; Vasile, Enrico; Fornaro, Lorenzo Journal: European journal of cancer Issue: Volume 137(2020) Page Start: 108 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. First‐line treatment with FOLFOXIRI for advanced pancreatic cancer in clinical practice: Patients' outcome and analysis of prognostic factors. Issue 4 (18th April 2016) Authors: Vivaldi, Caterina; Caparello, Chiara; Musettini, Gianna; Pasquini, Giulia; Catanese, Silvia; Fornaro, Lorenzo; Lencioni, Monica; Falcone, Alfredo; Vasile, Enrico Journal: International journal of cancer Issue: Volume 139:Issue 4(2016:Aug. 15) Page Start: 938 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. FOLFIRINOX after first-line gemcitabine-based chemotherapy in advanced pancreatic cancer: a retrospective comparison with FOLFOX and FOLFIRI schedules. (September 2020) Authors: Foschini, Francesca; Napolitano, Fabiana; Servetto, Alberto; Marciano, Roberta; Mozzillo, Eleonora; Carratù, Anna Chiara; Santaniello, Antonio; De Placido, Pietro; Cascetta, Priscilla; Butturini, Giovanni; Frigerio, Isabella; Regi, Paolo; Silvestris, Nicola; Delcuratolo, Sabina; Vasile, Enrico; V... Journal: Therapeutic advances in medical oncology Issue: Volume 12(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗